On September 16, 2026, President Trump issued a Presidential Memorandum (the “Memorandum”) titled “Restoring Reciprocity in Government Procurement,” which aims to remove Canadian origin items from the U.S. government procurement system.  The Memorandum provides few details on how this policy goal should be effectuated, but directs the following actions:

  • The Office of Management and Budget (“OMB”) Director and U.S. Trade Representative, in coordination with the FAR Council, and in consultation with other senior officials as appropriate, shall “to the extent appropriate and consistent with law, identify and take all steps permitted by applicable law with respect to Canadian origin items in the Federal civil procurement system that can, where warranted, be removed or made non-available for purchase.”
  • The OMB Director, in consultation with other senior officials as appropriate, shall also “notify” relevant executive departments and agencies of domestic alternatives to Canadian origin items, “to the extent permitted by law.”

As the Memorandum recognizes, Canada and the United States are both parties to the World Trade Organization Government Procurement Agreement (“WTO GPA”), a multilateral trade agreement intended to facilitate increased transparency and market access in government procurement among its members.  Under the WTO GPA, the United States is generally obligated to treat goods and services of Canada as favorably as goods and services of the United States and other GPA Members in covered procurements, prohibiting origin-based discrimination in such circumstances.  The Memorandum is clear that the directed actions should be taken to the extent permitted by existing law, and it is not clear how those actions will be squared with the United States’ obligations under the WTO GPA.  We note that the Trump Administration has repeatedly invoked security exceptions to WTO and other trade agreements in imposing tariffs or other trade measures otherwise inconsistent with such agreements in recent months.  It is also not clear by what standard a good in the U.S. federal procurement system would be determined to be of “Canadian origin.” 

Issuance of the Memorandum follows a recent escalation in U.S.-Canadian economic tensions, which have been tied in part to Canadian actions in the area of procurement taken in response to U.S. tariff measures.  The Memorandum states that the U.S. directives are in response to actions taken by Canada, including the “Buy Canadian” policy implemented in December 2025, and suggests that the directives could be rescinded if Canada changes its policies.  We will continue to monitor developments related to the Memorandum and report on them here.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Jennifer Plitsch Jennifer Plitsch

Jennifer Plitsch is a member of the Government Contracts Practice Group, where she works with clients on a broad range of issues arising from both defense and civilian contracts including contract proposal, performance, and compliance questions as well as litigation, transactional, and legislative…

Jennifer Plitsch is a member of the Government Contracts Practice Group, where she works with clients on a broad range of issues arising from both defense and civilian contracts including contract proposal, performance, and compliance questions as well as litigation, transactional, and legislative issues.

She has particular expertise in advising clients on intellectual property and data rights issues under the Federal Acquisition Regulations (FAR) and obligations imposed by the Bayh-Dole Act, including march-in and substantial domestic manufacturing. Jen also has significant experience in negotiation and compliance under non-traditional government agreements including Other Transaction Authority agreements (OTAs), Cooperative Research and Development Agreements (CRADAs), Cooperative Agreements, Grants, and Small Business Innovation Research agreements.

For over 20 years, Jen’s practice has focused on advising clients in the pharmaceutical, biologics and medical device industry on all aspects of both commercial and non-commercial agreements with various government agencies including:

the Department of Veterans Affairs (VA);
the Department of Health and Human Services (HHS), including the Biomedical Advanced Research and Development Authority (BARDA), the National Institutes of Health (NIH), and the Centers for Disease Control (CDC);
the Department of Defense (DoD), including the Defense Threat Reduction Agency (DTRA), the Defense Advanced Research Projects Agency (DARPA), and the Joint Program Executive Office for Chemical Biological Defense (JPEO-CBRN); and
the U.S. Agency for International Development (USAID).

She regularly advises on the development, production, and supply to the government of vaccines and other medical countermeasures addressing threats such as COVID-19, Ebola, Zika, MERS-CoV, Smallpox, seasonal and pandemic influenza, tropical diseases, botulinum toxin, nerve agents, and radiation events. In addition, for commercial drugs, biologics, and medical devices, Jen advises on Federal Supply Schedule contracts, including the complex pricing requirements imposed on products under the Veterans Health Care Act, as well as on the obligations imposed by participation in the 340B Drug Pricing program.

Jen also has significant experience in domestic sourcing compliance under the Buy American Act (BAA) and the Trade Agreements Act (TAA), including regulatory analysis and comments, certifications, investigations, and disclosures (including under the Acetris decision and Biden Administration Executive Orders). She also advises on prevailing wage requirements, including those imposed through the Davis-Bacon Act and the Service Contract Labor Standards.

Photo of Kayleigh Scalzo Kayleigh Scalzo

Ranked by Chambers USA among government contracts practitioners, Kayleigh Scalzo represents government contractors in bid protests and other high-stakes litigation matters with the government and other private parties. She has litigated bid protests in a wide variety of forums, including the Government Accountability…

Ranked by Chambers USA among government contracts practitioners, Kayleigh Scalzo represents government contractors in bid protests and other high-stakes litigation matters with the government and other private parties. She has litigated bid protests in a wide variety of forums, including the Government Accountability Office, U.S. Court of Federal Claims, U.S. Court of Appeals for the Federal Circuit, FAA Office of Dispute Resolution for Acquisition, federal and state agencies, and state courts.

Kayleigh is a former co-chair and current vice-chair of the American Bar Association Public Contract Law Section’s Bid Protest Committee. She is also a frequent speaker on bid protest issues.

Kayleigh maintains an active pro bono practice focused on immigration issues and gender rights.

Photo of Kate McNulty Kate McNulty

Kate McNulty advises U.S. and international clients on a range of complex international trade issues, dynamic U.S. and global tariff matters, and related trade compliance questions, including tariff stacking. She provides legal, policy, and strategic advice to companies, trade associations, and governments on…

Kate McNulty advises U.S. and international clients on a range of complex international trade issues, dynamic U.S. and global tariff matters, and related trade compliance questions, including tariff stacking. She provides legal, policy, and strategic advice to companies, trade associations, and governments on international economic policy matters, and assists clients in navigating geopolitical risk. She advises clients on the negotiation and enforcement of international trade agreements, including enforcement proceedings arising under the facility-specific rapid response labor mechanism of the USMCA.

Kate regularly represents clients before U.S. agencies such as the Office of the U.S. Trade Representative (USTR) and the U.S. Department of Commerce, including in proceedings arising under Section 301 of the Trade Act of 1974 and Section 232 of the Trade Expansion Act of 1962. She also litigates before the U.S. Court of International Trade and represents clients in antidumping and countervailing duty (AD/CVD) proceedings.

Prior to joining Covington, Kate held various positions in the U.S. government. Most recently, Kate served in the Office of Multilateral Trade Affairs at the U.S. Department of State from 2009 to 2018, where she managed trade enforcement matters for the Department—including U.S. government actions under Section 301 and Section 232—and also participated in the negotiation of international trade agreements on behalf of the U.S. government.

Photo of Jennifer Bentley Jennifer Bentley

Jennifer Bentley represents government contractors in a range of matters, with an emphasis on litigation, investigations, claims and disputes, and regulatory counseling. She also has deep expertise in government contracts domestic sourcing and supply chain issues, including the Buy American Act, Trade Agreements…

Jennifer Bentley represents government contractors in a range of matters, with an emphasis on litigation, investigations, claims and disputes, and regulatory counseling. She also has deep expertise in government contracts domestic sourcing and supply chain issues, including the Buy American Act, Trade Agreements Act, Build America, Buy America, and the BIOSECURE Act.

She has represented government contractors in False Claims Act investigations, prime-subcontractor disputes in federal court, disputes before the Armed Services Board of Contract Appeals, cost accounting disputes, and bid protests at the Government Accountability Office and U.S. Court of Federal Claims. She maintains an active pro bono practice.